Envista Holdings Corporation $NVST Stock Sold by Pzena Investment Management LLC

Pzena Investment Management LLC trimmed its position in Envista Holdings Corporation (NYSE:NVST) by 1.8% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,136,001 shares of the company’s stock after selling 21,272 shares during the quarter. Pzena Investment Management LLC owned approximately 0.71% of Envista worth $26,662,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the company. Arrowstreet Capital Limited Partnership grew its holdings in Envista by 341.5% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,858,293 shares of the company’s stock worth $72,515,000 after purchasing an additional 2,210,847 shares during the period. Wellington Management Group LLP lifted its position in shares of Envista by 2,662.1% in the second quarter. Wellington Management Group LLP now owns 1,686,415 shares of the company’s stock valued at $44,437,000 after buying an additional 1,625,360 shares during the last quarter. Bank of New York Mellon Corp acquired a new stake in shares of Envista in the second quarter valued at approximately $37,316,000. Renaissance Technologies LLC lifted its position in shares of Envista by 195.9% in the first quarter. Renaissance Technologies LLC now owns 1,208,165 shares of the company’s stock valued at $30,651,000 after buying an additional 799,900 shares during the last quarter. Finally, Quantinno Capital Management LP boosted its stake in shares of Envista by 38.8% during the 1st quarter. Quantinno Capital Management LP now owns 2,694,970 shares of the company’s stock worth $68,371,000 after acquiring an additional 753,474 shares during the period.

Envista Stock Performance

NVST opened at $24.91 on Friday. The business has a fifty day simple moving average of $24.43 and a 200 day simple moving average of $25.73. The company has a market capitalization of $4.00 billion, a PE ratio of 6.44, a price-to-earnings-growth ratio of 1.38 and a beta of 0.94. Envista Holdings Corporation has a 1 year low of $18.77 and a 1 year high of $30.42. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.43 and a quick ratio of 2.07.

Envista (NYSE:NVST) last issued its quarterly earnings data on Wednesday, November 4th. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.04. The firm had revenue of $691.50 million for the quarter, compared to analyst estimates of $688.74 million. Envista had a return on equity of 8.26% and a net margin of 22.01%. The company’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.32 EPS. Research analysts expect that Envista Holdings Corporation will post 1.53 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. Mizuho set a $29.00 target price on Envista in a report on Thursday, August 6th. Deutsche Bank Aktiengesellschaft set a $32.00 price target on Envista in a report on Thursday, September 3rd. Robert W. Baird downgraded Envista from an “outperform” rating to a “neutral” rating and cut their price target for the company from $34.00 to $26.00 in a report on Thursday, October 15th. UBS Group lifted their price objective on shares of Envista from $27.00 to $29.00 and gave the stock a “neutral” rating in a research report on Thursday. Finally, Wall Street Zen lowered shares of Envista from a “strong-buy” rating to a “buy” rating in a research report on Saturday, September 5th. Six equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $29.00.

Insider Activity

In related news, SVP Mischa Reis sold 8,000 shares of the company’s stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $27.50, for a total value of $220,000.00. Following the transaction, the senior vice president directly owned 27,321 shares in the company, valued at approximately $751,327.50. This represents a 22.65% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.99% of the company’s stock.

Key Headlines Impacting Envista

Here are the key news stories impacting Envista this week:

• Positive Sentiment: Envista reported Q3 earnings of $0.40 per share, above the $0.36 consensus, and revenue of $691.5 million versus estimates of $688.7 million. Revenue rose 3.2% year over year. Envista Q3 2026 results
• Positive Sentiment: The company raised its 2026 earnings outlook, citing pricing and productivity gains, signaling improved expectations for the current year. Q3 call highlights
• Neutral Sentiment: UBS raised its price target to $29 from $27 but maintained a neutral rating, suggesting a more constructive valuation view without a bullish recommendation. UBS analyst recommendations
• Negative Sentiment: Investors may be focused on China’s procurement reforms, which Envista flagged as a threat to margins as it moves toward 2027. That longer-term risk could outweigh the earnings beat and higher 2026 outlook in the near term. Q3 call highlights

Envista Company Profile

Envista Holdings Corporation (NYSE: NVST) is a global dental products and technologies company headquartered in Brea, California. The company develops, manufactures and markets products used by dentists, dental specialists, dental laboratories and other oral health professionals.

Envista’s portfolio includes dental implants, orthodontic systems, digital imaging and workflow solutions, dental consumables, treatment equipment and related technologies. Its brands include Nobel Biocare, Ormco, DEXIS and Kerr, which provide products and services spanning implant dentistry, orthodontics, diagnostic imaging, restorative care and general dental practice management.

Envista was established as an independent public company in 2019 following its separation from Danaher Corporation.